Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.
Ana Paula de AzambujaFabíola GevertRaisa Merhy OliveiraAna Paula Martins SebastiãoAnne Karoline GrothPublished in: Cytometry. Part B, Clinical cytometry (2021)
Use of MFC with a comprehensive antibody panel consisting of CD30 in conjunction with CD25 and HLA-DR can discriminate anaplastic cells of BIA-ALCL from lymphoid or neutrophilic reactive cells and should be considered in the initial evaluation of seroma.